{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:35:19Z","timestamp":1791858919396,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtct.2025.12.999","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:39:43Z","timestamp":1768005583000},"page":"619.e1-619.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Impact of Endothelial Dysfunction Events and Veno-Occlusive Disease in Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Retrospective Analysis From the Argentinian Group of Marrow Transplant and Cellular Therapy (GATMO-TC)"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8589-799X","authenticated-orcid":false,"given":"Gonzalo","family":"Bentolila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes de Jes\u00fas","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Vitriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Martinez Rolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lisa","family":"Basquiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtct.2025.12.999_bib0001","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.999_bib0002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2025.12.999_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050994","article-title":"Early vascular endothelial complications after hematopoietic cell transplantation: role of the endotheliopathy in biomarkers and target therapies development","volume":"13","author":"Moreno-Casta\u00f1o","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2025.12.999_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.999_bib0005","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.12.999_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.999_bib0007","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease Following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.999_bib0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.999_bib0009","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1509277","article-title":"Inotuzumab Ozogamicin versus standard therapy for acute lymphoblastic leukemia","volume":"375","author":"Kantarjian","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.999_bib0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","article-title":"Gemtuzumab Ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project","volume":"31","author":"McKoy","year":"2007","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.999_bib0011","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.999_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.999_bib0013","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41409-024-02215-4","article-title":"Utility of the refined EBMT diagnostic and severity criteria 2023 for Sinusoidal obstruction syndrome\/veno-occlusive disease","volume":"59","author":"Ichikawa","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.999_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.999_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.999_bib0016","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41409-022-01630-9","article-title":"Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012","volume":"57","author":"Correa","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.999_bib0017","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41409-023-02077-2","article-title":"Current incidence, severity, and management of Veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT transplant complications working party Study","volume":"58","author":"Ruutu","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.999_bib0018","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41409-025-02570-w","volume":"60","author":"Ravaioli","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.999_bib0019","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.999_bib0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.999_bib0021","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1182\/bloodadvances.2023011233","article-title":"Incidence and risk factors of early onset VOD\/SOS differ in younger vs older adults after stem cell transplantation","volume":"8","author":"Marcoux","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.999_bib0022","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.999_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10428194.2015.1041387","article-title":"High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma","volume":"57","author":"Hwang","year":"2016","journal-title":"Leuk Lymph"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.999_bib0024","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.leukres.2013.06.024","article-title":"Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia","volume":"37","author":"Kim","year":"2013","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.999_bib0025","doi-asserted-by":"crossref","first-page":"914.e1","DOI":"10.1016\/j.jtct.2024.06.003","volume":"30","author":"G\u00f3mez-Centuri\u00f3n","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.999_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.999_bib0027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.999_bib0028","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/bmt.2014.168","article-title":"Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen","volume":"49","author":"Tsirigotis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"1-2","key":"10.1016\/j.jtct.2025.12.999_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.05.001","article-title":"Defibrotide: properties and clinical use of an old\/new drug","volume":"59","author":"Pescador","year":"2013","journal-title":"Vascul Pharmacol"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.999_bib0030","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/bloodadvances.2017008375","article-title":"The use of defibrotide in blood and marrow transplantation","volume":"2","author":"Richardson","year":"2018","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.999_bib0031","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","article-title":"Endothelial damage and dysfunction in acute graft-versus-host disease","volume":"106","author":"Cordes","year":"2020","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.jtct.2025.12.999_bib0032","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2016-08-736314","article-title":"Initiation of acute graft-versus-host disease by angiogenesis","volume":"129","author":"Riesner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.999_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033490","article-title":"Role of endothelial cells in graft-versus-host disease","volume":"13","author":"Neidemire-Colley","year":"2022","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.jtct.2025.12.999_bib0034","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/bloodadvances.2021004941","article-title":"Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the chronic GVHD consortium","volume":"5","author":"DeFilipp","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.999_bib0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ajh.26870","article-title":"Younger haploidentical donor versus older matched unrelated donor for patients with AML\/MDS","volume":"98","author":"Marcoux","year":"2023","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.999_bib0036","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"25","key":"10.1016\/j.jtct.2025.12.999_bib0037","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725027344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725027344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:09:18Z","timestamp":1780312158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725027344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666636725027344"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.999","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Impact of Endothelial Dysfunction Events and Veno-Occlusive Disease in Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide: A Retrospective Analysis From the Argentinian Group of Marrow Transplant and Cellular Therapy (GATMO-TC)","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}